comparemela.com

Latest Breaking News On - Sangamo therapeutics - Page 2 : comparemela.com

HC Wainwright Reaffirms Buy Rating for Sangamo Therapeutics (NASDAQ:SGMO)

HC Wainwright reissued their buy rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $5.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at […]

US$3 50 - That s What Analysts Think Sangamo Therapeutics, Inc (NASDAQ:SGMO) Is Worth After These Results

US$3 50 - That s What Analysts Think Sangamo Therapeutics, Inc (NASDAQ:SGMO) Is Worth After These Results
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

SGMO Stock Earnings: Sangamo Therapeutics Misses EPS, Misses Revenue for Q1 2024

SGMO Stock Earnings: Sangamo Therapeutics Misses EPS, Misses Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.